Financial Covenants in Private Credit Transactions

Financial covenants remain a foundational component of private credit documentation. In a market defined by concentrated lender groups, sponsor-driven transactions and buy-and-hold investment strategies, financial covenants operate as both monitoring tools and structured frameworks for engagement over the life of a loan. Although competitive pressures have introduced incremental flexibility in certain segments, leverage-based maintenance testing continues to anchor the vast majority of private credit structures.

This article examines how financial covenants function in credit agreements and how they are adapted across business models, with particular emphasis on the leverage ratio and its structural implications.

Unlike broadly syndicated loan markets, private credit lenders rely on contractual protections to monitor performance, manage risk and preserve value. In this environment, financial covenants are central to the lender-borrower relationship. They provide visibility into financial condition, establish defined engagement points if performance deteriorates, and frame the negotiation dynamic when borrowers pursue transformative transactions.

Importantly, financial covenants in private credit are not designed primarily as enforcement triggers. They function as early-warning mechanisms intended to prompt dialogue while corrective action remains viable. As a result, the covenant package shapes not only legal rights but also the practical dynamics of lender-borrower engagement over time.

Usage in Credit Agreements

Financial covenants and other leverage-based tests serve multiple purposes in a credit agreement. They monitor ongoing performance, regulate specified borrower actions, and, in many cases, drive pricing and prepayment mechanics.

Ongoing performance is tested with financial maintenance covenants. These covenants require periodic — typically quarterly — compliance with specified financial metrics. Regular testing reinforces financial discipline and provides lenders with visibility into credit deterioration well before a payment default or insolvency event.

Incurrence tests operate differently. They are tested only when a borrower seeks to undertake a specified action, such as incurring additional indebtedness, making an acquisition, or paying a dividend. Incurrence tests are typically embedded in negative covenant “baskets”. To access a basket, the borrower must demonstrate compliance with the relevant financial test after giving pro forma effect to the proposed transaction.

The calibration of incurrence tests is a key underwriting decision. Unlike maintenance covenants, which may not be tested for months, incurrence tests assess risk at the moment a potentially credit-negative action is proposed. These tests may require compliance at the same level as the maintenance covenant. More often, however, they will be keyed off of closing leverage. Incurrence-based incremental debt baskets, for example, often require leverage at closing levels for pari passu secured debt or up to a quarter turn to a whole turn in excess of closing levels for junior lien or unsecured debt, while dividend and debt prepayment baskets typically require deleveraging (theoretically ensuring the company’s strong financial health prior to distributing money out of the credit pool ahead of the secured lenders). Properly structured, these tests encourage balance sheet discipline while preserving flexibility for sponsors to execute their business plans.

Leverage-based tests also influence economic terms. Leverage ratios commonly determine margin step-ups or step-downs and drive excess cash flow sweep percentages and other mandatory prepayment requirements. In this respect, leverage tests shape both risk allocation and pricing over the life of the loan.

Defining the Leverage Ratio

Because the leverage ratio drives maintenance testing, incurrence baskets, pricing mechanics, excess cash flow sweeps and, in many cases, amendment negotiations, its definition receives significant scrutiny and heavy negotiation between the parties. The formula — debt divided by EBITDA — is simple in concept, but its practical effect depends on how each component is defined.

Debt

For leverage purposes, debt is often defined more narrowly than what is monitored under the overall incurrence covenant. It typically includes funded indebtedness for borrowed money, bonds and notes, purchase money obligations, and capital leases. The treatment of earnouts, guarantees, preferred equity, and other hybrid instruments is negotiated. Earnouts that are due and payable are sometimes included; contingent earnouts valued on a “fair value” basis under generally accepted accounting principles (GAAP) are generally excluded from the leverage calculation. Undrawn letters of credit and preferred equity are typically excluded due to their contingent nature.

Depending on the capital structure, the leverage ratio may measure total debt or be limited to first lien or senior secured indebtedness.

Cash Netting

Most private credit leverage ratios permit some form of cash netting. Borrowers may deduct unrestricted cash from the debt numerator, subject to negotiated parameters. Key issues include whether netting is capped, which entities’ cash may be included (with a particular focus on cash held outside of the United States (for New York law governed deals) or at non-loan parties), and whether cash must be subject to a control agreement.

EBITDA

The EBITDA definition typically attracts substantial attention and negotiation from the parties. The focus on negotiations around EBITDA is driven by the usage of leverage based incurrence tests and covenant exceptions throughout credit documentation based on the aforementioned “baskets”, which are typically tied to a percentage of consolidated pro forma EBITDA. EBITDA begins with consolidated net income (a GAAP measure) and adds back interest, taxes, depreciation, and amortization. Most private credit agreements include additional adjustments, particularly for noncash items.

Common add-backs that are more highly negotiated include restructuring and integration costs; transaction expenses; extraordinary, unusual, or nonrecurring losses; pro forma synergies; run-rate adjustments; and company- or industry-specific items such as costs associated with new locations or research and development. Adjustments identified in sponsor models or quality of earnings reports are frequently incorporated.

Because expansive add-backs can materially affect leverage outcomes, lenders often impose caps (including, frequently, shared caps expressed as a percentage of EBITDA on certain projection-based or nonrecurring adjustments), time-based restrictions, or other limitations in an attempt to reflect actual operating cash flows of the business.

Pro Forma Calculations

Equally important are the rules governing pro forma calculations. Credit agreements frequently permit borrowers to include projected synergies, run-rate savings, and transaction-related adjustments in determining compliance. The scope and limits of these adjustments materially affect the practical reach of incurrence tests.

Testing Mechanics

As noted above, incurrence covenants are tested at the time of the proposed transaction. This can introduce timing challenges for transactions that require commitments (as in the acquisition context) or irrevocable notice (as for debt redemptions). To provide sponsors additional flexibility (and certainty of funds) to undertake these transactions without obtaining lender consents, credit agreements commonly include a “limited condition transaction” election permitting covenant testing at signing of a transaction rather than the closing, provided that specified fundamental conditions are satisfied at closing.

Maintenance covenants are typically tested quarterly and reported through compliance certificates delivered to the lenders with a company’s financial statements. As a result, a covenant breach may be unknown or uncertain until delivery of the compliance certificate (typically 45 to 60 days after the end of quarter). Lenders must be mindful of this context when determining the deadlines for delivering financial statements and any grace periods given to the borrower for failure to deliver financial statements or compliance certificates.

Aligning Covenants With the Business Model

While the leverage ratio dominates private credit documentation, covenant design is most effective when aligned with the borrower’s underlying business model. A formulaic approach rarely produces durable results.

For mature, predictable cash-flow businesses, EBITDA–based covenants are the market standard. The leverage ratio described above measures the ability of a company’s earnings to support its debt. It is a useful tool to assess the company’s overall risk profile, as it captures changes in both operating performance and the amount of debt in the capital structure. The leverage ratio is also important to the merger-and-acquisition side of the transaction, where sponsors also use EBITDA multiples to value companies and gauge sale prospects. Because of this, the leverage ratio is a ubiquitous tool that sponsors and lenders can use to compare a particular company’s risk profile with other borrowers in the market. In addition to a leverage ratio, covenant packages may include a fixed charge coverage ratio, which measures the ability of EBITDA (adjusted for unfinanced capital expenditures and other cash outlays) to service interest payments (an interest coverage ratio) and other fixed charges such as scheduled amortization.

Asset-intensive businesses require additional balance sheet sensitivity. Working capital cycles, capital expenditure requirements, and asset quality can drive credit outcomes as much as earnings performance. In these cases, leverage covenants are sometimes paired with liquidity-based protections, including minimum liquidity thresholds or borrowing base constructs.

Growth-oriented software and recurring-revenue businesses present a different profile. In expansion phases, EBITDA may not fully reflect enterprise value or credit strength. Market practice has therefore evolved to incorporate alternative metrics, such as an annual recurring revenue (ARR) covenant requiring a minimum annualized recurring revenue stream (adjusted for subscriber churn and retention) as a financial maintenance covenant and/or a cap on borrowing availability. These metrics focus on revenue durability and liquidity runway rather than near-term profitability.

Cyclical or seasonal businesses demand thoughtful calibration. Earnings volatility tied to commodity prices or seasonal demand can produce quarter-to-quarter swings that do not necessarily signal systemic deterioration. Trailing 12-month constructs, seasonal cushions, or staged covenant step-ups are commonly used to preserve the covenant’s early-warning function without triggering repeated technical breaches driven by predictable fluctuations.

Sponsor-backed growth credits often combine these approaches. Acquisition-driven or integration-focused strategies may introduce near-term variability while maintaining a credible long-term growth trajectory. As a result, maintenance leverage covenants are frequently paired with adjustments to EBITDA for acquisitions, incremental facilities, and equity cure rights. The objective is to preserve meaningful periodic monitoring while accommodating sponsor-led expansion initiatives.

Setting Covenant Levels

Covenant levels are typically set with deliberate headroom relative to the sponsor’s projections and may incorporate anticipated deleveraging over time. If set too tightly, covenants constrain operational flexibility and can lead to frequent amendments. On the other hand, if set too loosely, they may result in a borrower exhausting liquidity well before triggering a covenant breach which would prohibit the lenders’ ability to intervene proactively.

Effective calibration provides sufficient cushion to accommodate ordinary-course volatility but not so much that the covenant ceases to provide meaningful discipline. A typical leverage covenant in a direct lending transaction may be set with a 25-35% cushion to the EBITDA projected in a sponsor or borrower model that is prepared and delivered to the lender prior to closing. Cushions above this level may result in the so-called “cov-loose” structure mentioned above.

Structural Variations

Competitive dynamics, particularly in the competitive middle and upper market, have increased adoption of various covenant lite (or “cov-lite”) provisions, which are derived from the syndicated markets. In some cov-lite transactions, financial maintenance covenants benefit only revolving lenders, with term lenders receiving only cross-acceleration rights. Quarterly testing is triggered only if revolving credit usage exceeds a negotiated threshold of available revolving commitments (typically 40% or higher) and may incorporate cash netting and other negotiated exclusions, including closing revolver date advances for a limited period. In sponsor-friendly transactions, testing can be avoided if revolving credit usage is reduced below the testing threshold after the covenant test date but before delivery of the compliance certificate.

Additional cov-lite variations include covenant ratchets and covenant holidays. Ratchets allow borrowers to reset covenant levels upward following incremental borrowings, reflecting increased leverage. Covenant holidays suspend or soften testing for a defined period following a material acquisition. Each mechanism reflects a market effort to align covenant discipline with transactional activity without permanently relaxing structural protections.

Unrestricted Subsidiaries

The scope of entities included in leverage calculations also matters. EBITDA generally includes the borrower and its GAAP-consolidated subsidiaries. However, credit agreements in the competitive sponsor-backed market may permit designation of “unrestricted subsidiaries” that fall outside the covenant framework. These subsidiaries, along with joint ventures or minority investments, are usually excluded from financial covenant calculations except to the extent they distribute actual cash earnings to a loan party or restricted subsidiary.

Cure Rights

Equity cure rights are common in sponsor-backed private credit transactions. These provisions allow sponsors to restore compliance with maintenance covenants by contributing additional capital in the form of equity or, in some cases, subordinated debt. Some agreements also allow sponsors to count previously contributed equity toward the required cure amount. Cure proceeds are deemed to increase EBITDA solely for maintenance covenant compliance purposes for the applicable test period and each subsequent test period including the cure quarter and not for other calculations under the agreement. Sponsors are given a limited cure period, during which lenders are typically restricted from accelerating the loan or engaging in remedies but are not required to fund additional advances.

Cure rights are subject to negotiated frequency and timing limitations, and cure proceeds may be required to reduce outstanding debt.

Conclusion

Financial covenants remain central to private credit transactions. Although structures continue to evolve, leverage-based maintenance testing remains the structural backbone of most agreements. The most durable covenant packages combine calibrated flexibility with clear drafting and disciplined definitions. When aligned with the borrower’s business model and capital structure, covenants provide meaningful early-warning signals without impeding the daily operations and growth plans of borrowers.

As private credit continues to expand across industries and transaction types, thoughtful covenant design will remain integral to how lenders, borrowers, and sponsors allocate risk, preserve optionality, and manage performance over the life of a transaction.